3 Dividend Stocks to Buy Now for a Lifetime of Passive Income

09:23am, Monday, 17'th Oct 2022 The Motley Fool
These ultra-reliable businesses could deliver quarterly payments that steadily grow throughout your retirement.
These ultra-reliable businesses could deliver quarterly payments that steadily grow throughout your retirement.
Trading penny stocks right now? Here's what to watch in the stock market this week October 17, 2022 to October 21, 2022.
All three of these medical stocks offer a high-yield dividend.

3 Beaten-Down Stocks to Buy and Hold

01:53pm, Saturday, 15'th Oct 2022 The Motley Fool
These stocks could be ready for big bounces.
The news comes after a February recall on formula that prompted a widespread shortage and national crisis as parents struggled to feed their children.

3 Beaten-Down Stocks to Buy and Hold

09:53am, Saturday, 15'th Oct 2022
These stocks could be ready for big bounces.

Abbott (ABT) Stock Moves -1.52%: What You Should Know

09:50pm, Friday, 14'th Oct 2022 Zacks Investment Research
Abbott (ABT) closed the most recent trading day at $100.91, moving -1.52% from the previous trading session.

Abbott Issues New Baby Formula Recall

05:56pm, Friday, 14'th Oct 2022
Abbott, the baby formula manufacturer, said Friday it's recalling some lots of its "ready-to-feed" liquid products and formulas in 2-ounce containers. A "small percentage" of the bottles may not have

Here's How Investors Can Find Strong Medical Stocks with the Zacks ESP Screener

12:50pm, Friday, 14'th Oct 2022 Zacks Investment Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

What's in Store for Abbott Laboratories (ABT) in Q3 Earnings?

05:05pm, Thursday, 13'th Oct 2022 Zacks Investment Research
Going by the industry-wide trend so far, logistical challenges and increasing unit costs might have weighed on the corporate profitability of Abbott (ABT) in Q3.

Why Abbott (ABT) Could Beat Earnings Estimates Again

04:10pm, Thursday, 13'th Oct 2022 Zacks Investment Research
Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Going by the industry-wide trend so far, logistical challenges and increasing unit costs might have weighed on the corporate profitability of Abbott (ABT) in Q3.
Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why the Bear Market May Not Be Over Anytime Soon

09:30am, Thursday, 13'th Oct 2022 The Motley Fool
Are investors better off waiting until next year to buy stocks?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE